전체메뉴 닫기
진료예약·상담
진료일정
진료예약

진료예약 안내

처음진료 빠른예약

전화예약

FAX예약

방문예약

영유아건강검진 예약

건강검진 예약상담

예약조회·취소

1:1전문의상담

진료과별 상담

이용안내 FAQ

고마워요 차병원
진료과·의료진
의료진 한 눈에 보기
센터·진료과 찾기

센터 리스트

진료과 리스트

클리닉 리스트

진료과·의료진 검색

쉬운 진료과 찾기

질환별 찾기

진료과별 FAQ

산부인과 FAQ

소아청소년과 FAQ

비뇨의학과 FAQ

이용안내
처음오시는분
외래·응급·입원

외래진료안내

응급진료안내

건강보험안내

입퇴원·면회안내

입원생활안내

비급여수가안내
병원 층별 안내
편의시설

상가 B1

상가 1F

상가 2F

상가 3F

주요전화번호
증명서발급안내

진단서 및 증명서

의무기록사본

온라인 신청

찾아오시는길

약도·자가용

대중교통안내

주차안내

마티네 차움 산후조리원

마티네 차움

산후조리 서비스

신생아 케어

스파 & 브레스트 케어

G·X

상생의원

성형외과·피부과

정형외과

치과

함께 만들어요(고객의 소리)
건강정보
건강강좌

이달의 건강강좌

산모대학 무료공개강좌

태교학교

육아교실

난임교실

생애주기 여성건강교실

건강라이프 칼럼
CHA 유튜브
건강한 출산 A to Z

임신준비관리

산전관리

분만관리

산후관리

아기관리

항상 최고의 진료를
약속합니다

비뇨의학과 송재만 교수

일반진료
오전 진료 진료
오후 진료 진료 진료

전문분야

비뇨기계 종양(신장암, 요로상피세포암, 전립선암, 고환암), 전립선 비대, 남녀 배뇨장애

교수 경력

  • 연세대학교
  • 차의과학대학교

진료 경력

  • 미국 Mayo Clinic Urology Research Fellow
  • 연세대학교 원주세브란스기독병원 병원장
  • 연세대학교 원주세브란스의료원 의료원장
  • 차의과학대학교 일산차병원 비뇨의학과

학회·연구·연수·수상 경력

  • 대한비뇨기과학회 수련이사
  • 미국비뇨기과학회 Corresponding & International member
  • 대한비뇨종양학회 이사 및 자문위원
  • 세계비뇨내시경학회 정회원
  • 대한비뇨기과학회 명예회장
  • 대한비뇨기과학회 최우수 학술상(1995)

  • 언론기사·영상
  • 논문
  1. 부고환에 발생한 Adenomatoid Tumor 1례.//19791201/Korean J Urol
  2. A Case of Prenephrectomy Renal Artery Embolization for Renal Cell Carcinoma. Korean J Urol 1979 Jun 20(3): 320-324.//19790601/Korean J Urol
  3. 요로주혈흡층증 1례//19810101/Korean J Urol
  4. Creation of Artificial Spermatocele in Aplasia of the Vas Deferens. Korean J Urol 1981 Dec 22(6): 637-640.//19810601/ Korean J Urol
  5. Clinical Observation of Transurethral Prostatectomy. Korean J Urol 1981 Oct 022(05): 383-390.//19811001/ Korean J Urol
  6. Significance of Prostatic Needle Biopsy in Diagnosis of Prostatic Carcinoma. Korean J Urol 1981 Dec 22(6): 637-640. //19811201/ Korean J Urol
  7. Traumatic Ureteral Avulsion due to Blunt Trauma. Korean J Urol 1982 Apr 023(02): 188-190. //19820401/ Korean J Urol
  8. Visual internal Urethrotomy in the Management of Urethral Stricture: A Clinical Review. Korean J Urol 1986 Aug 027(04): 545-548.//19860801/ Korean J Urol
  9. Unusual Bladder Stones -Report of Three Cases- Korean J Urol 1986 Oct 027(05): 757-761.//19861001/ Korean J Urol
  10. Intrathoracic Kidney: Report of A Case. Korean J Urol 1987 Feb 028(01): 133-135.//19870201/ Korean J Urol
  11. Direct Visual Internal Urethrotomy as an Effective Treatment Modality for Traumatic Complete Urethral Stricture. Korean J Urol 1987 Feb 028(01): 35-38.//19870201/ Korean J Urol
  12. A Case of Pyeloplasty in Neonatal Bilateral U-P-J Obstruction.  J Korean Pediatr Soc. 1987 Nov;30(11):1294-1298.//19871101/ Korean J Urol
  13. Significance of CT Scan as a Diagnostic Tool in Renal Injury Associated with Abdominal Trauma. Korean J Urol 1988 Feb 029(01): 77-82.//19880201/ Korean J Urol
  14. Clinical Observation of Bladder Rupture due to Blunt Trauma. Korean J Urol 1988 Jun 029(03): 477-480.//19880601/ Korean J Urol
  15. Modified Orandi and blandy-Singh Vasculized Island Skin Flap Urethroplasty Performed Simultaneously in a Case of long Penile and Bulbous Urethral Striture. Korean J Urol 1988 Dec 029(04): 575-578.//19881201/ Korean J Urol
  16. Hamartoma of the urachal remnant//19890401/ Korean J Urol
  17. Clinical Significance of Intracavernous Injection of Papaverine and Snap-Gauge Test in Diagnosis of Impotent Patients. The Journal of Wonju College of Medicine 1989 2(01): 83-86.//19890601/The Journal of Wonju College of Medicine
  18. Primary adenocarcinoma of the bladder: favorable prognostic significance of deoxyribonucleic acid diploidy measured by flow cytometry. J Urol. 1990 Nov;144(5):1115-8./2.719/19901101/J Urol.
  19. Transitional Cell Carcinoma of the Upper Urinary Tract: Evaluation of Prognostic Factors by Histopathology and Flow Cytometric Analysis J Urol. 1991 Jun;145(6):1159-63./2.685/19910601/J Urol.
  20. A Case of Apocrine Sweat Gland Carcinoma in the Scrotum. Korean J Urol 1991 Oct 032(05): 853-856.//19911001/Korean J Urol
  21. Nuclear deoxyribonucleic acid content measured by static cytometry: important prognostic association for patients with clinically localized prostate carcinoma treated by external beam radiotherapy. J Urol. 1992 Mar;147(3 Pt 2):794-7./2.486/19920301/J Urol.
  22. Leiomyoma of the vagina. Korean J Obstet Gynecol. 1993 Jan;36(1):135-137//19930101/Korean J Obstet Gynecol.
  23. Effects of Digital Rectal Examination and Transurethral Resection of the Prostate on Serum Prostate-Specific Antigen and Acid Phosphatase Levels. Korean J Urol 1993 Feb 034(01): 61-67.//19930201/Korean J Urol
  24. The Relationship Among PSA Levels, Prostatic Volume and Resected Prostate Weight. Korean J Urol 1993 Apr 034(02): 246-251.//19930401/Korean J Urol
  25. A Case of Bilateral Renal Angiomyolipoma Associated with Tuberous Sclerosis. Korean J Urol 1993 Jun 034(03): 553-556.//19930601/Korean J Urol
  26. Clinical Experience of Early Catheter Removal Following Transurethral Resection of the Prostate. Korean J Urol 1993 Jun 034(03): 448-451.//19930601/Korean J Urol
  27. The influence of age and endocrine factors on the volume of benign prostatic hyperplasia. Korean J Urol. 1993 Oct;34(5):850-854.//19931001/Korean J Urol
  28. Schwannoma of the Urinary Bladder Wall : A Case Report. Korean J Urol 1993 Dec 034(06): 1076-1079.//19931201/Korean J Urol
  29. Factors Affecting the Morbidity after Transurethral Prostatectomy for Benign Prostatic Hyperplasia. Korean J Urol. 1994 Feb;35(2):165-171. //19940201/Korean J Urol
  30. A 24 week Double-blind, Placebo-controlled Study using Terazosin in Treatment of Benign Prostatic Hyperplasia. Korean J Urol. 1994 Jul;35(7):755-759.//19940701/Korean J Urol
  31. Inverted Papilloma of the Renal Pelvis. Korean J Urol 1994 Aug 035(08): 894-897.//19940801/Korean J Urol
  32. Juvenile Benign Prostatic Hyperplasia: A Case Report. Korean J Urol 1994 Sep 035(09): 1023-1026.//19940901/Korean J Urol
  33. Microsurgical Anatomy and the Function of the Ureterovesical Junction. Korean J Urol 1994 Sep 035(09): 923-936.//19940901/Korean J Urol
  34. Prognostic Significance of Deoxyribonucleic acid in Stage T1 Bladder Carcinoma. Korean J Urol. 1994 Dec;35(12):1321-1326.//19941201/Korean J Urol
  35. Clinical Significance of Age-Specific Reference Range of PSA. Korean J Urol 1995 Jan 036(01): 38-42.//19950101/Korean J Urol
  36. Effectiveness of Bladder Preservation Treatment For Patients with Superfcially Invasive Bladder Tumor(T2/T3a). Korean J Urol 1995 Jun 036(06): 601-608.//19950601/Korean J Urol
  37. The relevance between the post-operative voiding symptoms and the rate of resected weight to the prostatic volume. Korean J Urol. 1995 Nov;36(11):1225-1230. //19951101/Korean J Urol
  38. Clinical Significance of Measuring Free form of Prostate-Specific Antigen. Korean J Urol 1996 May 037(05): 510-515.//19960501/Korean J Urol
  39. Translation Validity and Reliability of I-PSS Korean Version. Korean J Urol 1996 Jun 037(06): 659-665.//19960601/Korean J Urol
  40. Ten Years Experience of Post-Traumatic Complete Urethral Stricture Treated with Endoscopic Internal Urethrotomy. Korean J Urol 1996 Nov 037(11): 1300-1307.//19961101/Korean J Urol
  41. Prevalence and Characteristics of Prostatism in Korea: Application of I-PSS. Korean J Urol 1997 Oct 038(10): 1067-1074.//19970801/Korean J Urol
  42. A New Surgical Approach to the Rectal Anastomotic Stricture: Endoscopic. J Korean Soc Coloproctol. 1997 Sep;13(3):529-534.//19970901/ Endoscopic. J Korean Soc Coloproctol
  43. The Study of Expression of p53 Protein and Its Clinical Significance in Transitional Cell Carcinoma of the Urinary Bladder. Korean J Urol 1997 Nov 038(11): 1137-1146.//19971101/Korean J Urol
  44. A Case of Inflammatory Pseudotumor In the Urinary Bladder. Korean J Urol 2000 Jan 041(01): 194-195.//20000101/Korean J Urol
  45. Metastatic Renal Cell Carcinoma to the Prostate: a Case Report. Korean J Urol 2000 Jan 041(01): 187-188.//20000101/Korean J Urol
  46. Clinical Assessment of Transurethral Resection of Prostate (TURP) using Continuous Irrigating System. Korean J Urol 2000 Oct 041(10): 1259-1263.//20001001/Korean J Urol
  47. A Case of Cavernous Hemangioma of the Urinary Bladder. Korean J Urol 2000 Oct 041(10): 1291-1294.//20001001/Korean J Urol
  48. The Prognostic Factor Analysis and Effect of Adjuvant M-VAC Chemotherapy on Advanced Transitional Cell Carcinoma of the Upper Urinary Tract. Korean J Urol 2001 Oct 042(10): 1028-1032.//20211001/Korean J Urol
  49. Vascular endothelial growth factor - its relation to neovascularization and their significance as prognostic factors in renal cell carcinoma. Yonsei Med J. 2001 Oct;42(5):539-46./0.382/20211001/ Yonsei Med J.
  50. Expression of Vascular Endothelial Growth Factor (VEGF) and Its Clinical Significance with Neovascularization in Conventional Renal Cell Carcinoma. Korean J Urol 2002 May 043(05): 353-359.//20210502/Korean J Urol
  51. Detrusor and Blood Pressure Responses to Dorsal Penile Nerve Stimulation during Hyper-reflexic Bladder Contraction in Patients with Cervical Cord Injury. J Korean Acad Rehabil Med. 2002 Aug;26(4):409-413//20210802/ J Korean Acad Rehabil Med.
  52. Paratesticular Rhabdomyosarcoma in an Adult. Korean J Urol 2002 Oct 043(10): 910-912.//20211002/Korean J Urol
  53. Effect of Angiotensin II Receptor Blockade on VEGF Expression in Diabetic Nephropathy. J Korean Diabetes Assoc. 2003 Apr;27(2):106-114.//20210403/ J Korean Diabetes Assoc.
  54. Current Status of Hormonal Therapy for Prostate Cancer in Korea: A National Survey of Korean Uro-Oncologists. Korean J Uro-Oncol 2003;1(2):175-180 //20210603/ Korean J Uro Oncol
  55. The 2nd conference on Asian trends in prostate cancer hormone therapy. Gan To Kagaku Ryoho 01 Oct 2003, 30(10):1533-1542//20211003/Gan To Kagaku Ryoho
  56. Effects of Soybean Metabolites on Prostate Cancer. Korean J Urol. 2003 Nov;44(11):1093-1097.//20211003/Korean J Urol
  57. Bladder Preservation Strategies for Treatment of Muscle-Invasive Bladder Cancer: Experience of 7-Year Follow up. Korean J Urol 2003;44:391-396.//20211103/Korean J Urol
  58. Effect of Smoking on Bladder Cancer as a Single Risk Factor. Korean J Urol. 2004 Jan;45(1):1-6//20210104/Korean J Urol
  59. Malacoplakia of the Prostate. Korean J Urol 2004 Jan 045(01): 93-95.//20210104/Korean J Urol
  60. Bladder Preservation Management for Muscle Invasive Bladder Cancer. Korean J Urol 2004 Jan 045(01): 19-23.//20210104/Korean J Urol
  61. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol. 2004 Feb;34(2):86-9./0.96/20210204/Jpn J Clin Oncol.
  62. A Multicenter Study of the Detection Rate for Prostate Cancer according to the Serum Prostate-Specific Antigen Level in Korean Men. The Korean Journal of Urology 2005 May 046(05): 433-437.//20210505/Korean J Urol
  63. Prostate-Specific Antigen, Digital Rectal Examination and Transrectal Ultrasonography: A Meta-Analysis for This Diagnostic Triad of Prostate Cancer in Symptomatic Korean Men. Yonsei Med J. 2005 Jun;46(3):414-424./0.628/20210605/ Yonsei Med J.
  64. Effects of Residual Prostatic Calculi on Lower Urinary Tract Symptoms after Transurethral Resection of Prostate. The Korean Journal of Urology 2005 Jun 046(06): 569-573.//20210605/Korean J Urol
  65. The Significance of Changes in Serum Prostate Specific Antigen Levels after a Transurethral Resection of the Prostate. The Korean Journal of Urology 2005 Jul 046(07): 704-707.//20210705/Korean J Urol
  66. Leiomyoma of the vagina that caused cyclic urinary retention. Acta Obstet Gynecol Scand. 2007;86(1):102-4.//20210705/Acta Obstet Gynecol Scand.
  67. The Influence of Age and Prostate Volume on the Cancer Detection Rate in Korean Men with PSA Levels of 4.0 to 10.0ng/ml: a Multicenter, Retrospective Study. The Korean Journal of Urology 2006 Apr 047(04): 353-357.//20210406/Korean J Urol
  68. The Use of Complementary and Alternative Medicine in Patients with a Urological Malignancy. The Korean Journal of Urology 2006 Jun 047(06): 620-624.//20210606/Korean J Urol
  69. Prostate cancer control--aims of the UICC Asia Regional Office Consortium. Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):350-68.//20210906/Asian Pac J Cancer Prev
  70. The 5th Conference on Asian Trends in Prostate Cancer Hormone Therapy. Asian Pac J Cancer Prev. 2007 Jan-Mar;8(1):3-12.//20210906/Asian Pac J Cancer Prev
  71. Prostate cancer control--aims of the UICC Asia Regional Office Consortium. Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):350-68.//20211006/Asian Pac J Cancer Prev
  72. A New Convenient Device of Circumcision. The Korean Journal of Urology 2006 Oct 047(10): 1099-1102.//20211006/Korean J Urol
  73. Predictive Variables of the Progression to Androgen Independent Prostate Cancer after Combined Androgen Blockade. The Korean Journal of Urology 2007 Apr 048(03): 408-415.//20210407/Korean J Urol
  74. Patients with benign prostatic hyperplasia with pathologic prostatitis: The effect on the surgical outcome. J Korean Continence Soc. 2008 Jun;12(1):73-77.//20210608/J Korean Continence Soc.
  75. Comparative Analysis of Real Size and Computed Tomography - Estimated Size of Adrenal Tumor. Korean J Urol Oncol 2008;6(3):122-126//20210608/Korean J Urol
  76. Expression of Nitric Oxide Synthase(NOS) in Rat Bladders Subjected to Short-term Partial Outlet Obstruction. The Korean Journal of Urology 2008 Jul 049(07): 622-626.//20210708/Korean J Urol
  77. Local Recurrence of Spermatic Cord Leiomyosarcoma. The Korean Journal of Urology 2009 Jan 050(01): 92-95.//20210109/Korean J Urol
  78. Translation and validation of the Korean version of MUDI and MUSIQ with urinary incontinent older men. Yonsei Med J. 2009 Feb/0.772/20210209/ Yonsei Med J.
  79. A large cystic phyllodes tumor of the prostate. Yonsei Med J. 2009 Feb 28;50(1):174-6.  /0.772/20210209/ Yonsei Med J.
  80. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men. Cancer Genet Cytogenet. 2009 Apr 15;190(2):88-92./1.537/20210409/Cancer Genet Cytogenet.
  81. The Multi-center Clinical Trial of Leuprolide Acetate Depot (LuphereⓇ Depot inj 3.75mg) for Evaluation of Efficacy and Safety in Patients with Prostate Cancer Korean J Urol Oncol 2009;7(1):21-26 //20210709/Korean J Urol
  82. Active Surveillance in Localized Prostate Cancer: When and How. Korean J Urol Oncol 2009;7(1):1-5//20210709/ Korean J Uro Oncol
  83. Failing to achieve a nadir prostate-specific antigen after combined androgen blockade: Predictive factors. Int J Urol. 2009 Aug;16(8):670-5/1.158/20210809/Int J Urol.
  84. Comparative Analysis of Outcomes after Transurethral Resection of the Prostate according to Prostate Shape Shown by Transrectal Ultrasonography. Korean J Urol. 2010 Jul;51(7):483-487.//20210710/Korean J Urol
  85. Prostate Cancer Working Group Report. Japanese Journal of Clinical Oncology, Volume 40, Issue suppl_1, 1 September 2010, Pages i70–i75/1.856/20210710/Jpn J Clin Oncol.
  86. Efficacy of Bladder-Preserving Therapy for Patients with T3b, T4a, and T4b Transitional Cell Carcinoma of the Bladder. Korean J Urol. 2010 Aug;51(8):525-530.//20210810/Korean J Urol
  87. Analysis of the Factors Causing Bladder Irritation after Transurethral Resection of the Prostate. Korean J Urol. 2010 Oct;51(10):700-703.//20211010/Korean J Urol
  88. Significance of perineural invasion, lymphovascular invasion, and high-grade prostatic intraepithelial neoplasia in robot-assisted laparoscopic radical prostatectomy. Ann Surg Oncol. 2011 Dec;18(13):3828-32./4.166/20211211/Ann Surg Oncol
  89. Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment. Korean J Urol. 2012 Mar;53(3):149-153//20210312/Korean J Urol
  90. Extended Pelvic Lymph Node Dissection Including Internal Iliac Packet Should Be Performed During Robot-Assisted Laparoscopic Radical Prostatectomy for High-Risk Prostate Cancer. J Laparoendosc Adv Surg Tech A. 2012 Oct;22(8):785-90. /1.066/20211012/J Laparoendosc Adv Surg Tech
  91. Relationships between Prostate-Specific Antigen, Prostate Volume, and Components of Metabolic Syndrome in Healthy Korean Men. Korean J Urol. 2012 Nov;53(11):774-778.//20211112/Korean J Urol
  92. Contribution of Genetic Variation rs266882 to Prostate-Specific Antigen Levels in Healthy Controls with Serum PSA Below 2.0 ng/ml. Biochem Genet. 2013 Apr;51(3-4):264-74/0.822/20210413/ Biochem Genet.
  93. Clinical effects of discontinuing 5-alpha reductase inhibitor in patients with benign prostatic hyperplasia. Korean J Urol. 2014 Jan;55(1):52-6. //20210114/Korean J Urol
  94. Simultaneous Robot-Assisted Laparoendoscopic Single-Site Partial Nephrectomy and Standard Radical Prostatectomy. Yonsei Med J. 2014 Mar;55(2):535-538. English./1.287/20210314/ Yonsei Med J.
  95. Clinical application of computed tomography on prostate volume estimation in patients with lower urinary tract symptoms. Urol J. 2014 Nov 30;11(6):1980-3./0.565/20211114/ Urol J.
  96. The incidence and histological characteristics of intratubular germ cell neoplasia in postpubertal cryptorchid testis. Korean J Urol. 2015 Jul;56(7):515-518.//20210715/Korean J Urol
  97. Clinical Significance of National Institutes of Health-Chronic Prostatitis Symptom Index Pain Score in Patients with Benign Prostatic Hyperplasia. Urogenit Tract Infect. 2015 Oct;10(2):102-107//20211015/ Urogenit Tract Infect.
  98. Penile Mass Caused by Mycobacterium tuberculosis. Urogenit Tract Infect. 2015 Oct;10(2):126-129.//20211015/ Urogenit Tract Infect.
  99. Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea. Int Neurourol J. 2016 Dec;20(4):321-328./1.739/20211216/Int Neurourol J.
  100. The Correlation between Body Mass Index and Routine Parameters in Men Over Fifty. World J Mens Health. 2017 Sep 6.//20210917/World J Mens Health